These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer. Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G; Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053 [TBL] [Abstract][Full Text] [Related]
26. Biological models of breast cancer: one size does not fit all. Choong LY; Lim YP Expert Rev Proteomics; 2011 Feb; 8(1):5-7. PubMed ID: 21329423 [No Abstract] [Full Text] [Related]
27. A new susceptibility locus for estrogen receptor-negative breast cancer. Maduro MR Reprod Sci; 2012 Jan; 19(1):5. PubMed ID: 22228736 [No Abstract] [Full Text] [Related]
28. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Tang C; Chen N; Wu M; Yuan H; Du Y Breast Cancer Res Treat; 2009 Sep; 117(2):391-9. PubMed ID: 19145484 [TBL] [Abstract][Full Text] [Related]
29. Association screening of common and rare genetic variants by penalized regression. Zhou H; Sehl ME; Sinsheimer JS; Lange K Bioinformatics; 2010 Oct; 26(19):2375-82. PubMed ID: 20693321 [TBL] [Abstract][Full Text] [Related]
33. Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway. Zhong W; Chen S; Qin Y; Zhang H; Wang H; Meng J; Huai L; Zhang Q; Yin T; Lei Y; Han J; He L; Sun B; Liu H; Liu Y; Zhou H; Sun T; Yang C Oncotarget; 2017 Dec; 8(62):104855-104866. PubMed ID: 29285218 [TBL] [Abstract][Full Text] [Related]
34. Beyond BRCA1/2: polygenic, 'polyfunctional' molecular circuitry model to predict breast cancer risk. Lianos GD; Zoras O; Roukos DH Biomark Med; 2013 Oct; 7(5):675-8. PubMed ID: 24044557 [No Abstract] [Full Text] [Related]
35. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival. Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604 [TBL] [Abstract][Full Text] [Related]
36. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk. Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608 [TBL] [Abstract][Full Text] [Related]
37. Worldwide study links two new genetic variants to breast cancer. Mayor S BMJ; 2015 Feb; 350():h653. PubMed ID: 25655755 [No Abstract] [Full Text] [Related]
38. Genome-wide association studies and the clinic: a focus on breast cancer. Véron A; Blein S; Cox DG Biomark Med; 2014; 8(2):287-96. PubMed ID: 24521025 [TBL] [Abstract][Full Text] [Related]